News

Sandoz, a biosimilars manufacturer, has announced the beginning of a new global campaign to combat global health disparities. By harnessing the '4 As' of biosimilars- approval, accessibility, acceptability, and affordability, Act4Biosimilars strives to expand patient access to innovative treatments....

After the United Kingdom and Argentina presented a "landmark" decision to the World Health Assembly in Geneva recently, the world took a huge step toward greater pandemic preparedness. More specific financing will be advocated for within the resolution, allowing developing...

The US Food and Drug Administration (FDA) has granted Novartis expedited approval for its CAR-T cell therapy Kymriah (tisagenlecleucel) to treat people with relapsed or refractory (r/r) follicular lymphoma (FL) following two or more lines of conventional therapy. As part...

NRG Therapeutics, a neuroscience firm, has been presented with the Biomedical Catalyst award. The £2.68 million package will be used to advance the pre-clinical development of the company's innovative small molecule disease-modifying medicines for the treatment of Parkinson's disease,...

The United Kingdom and Sweden have reached a deal through an MoU recognising their existing bilateral collaboration in the biological sciences. The goal of the MoU is to foster collaboration among participants in the health, research, as well as innovation systems...

Scientists have discovered a viable antiviral therapy for monkeypox, albeit the illness remains a considerably less serious threat than COVID, according to the researchers. As per new research on historical outbreaks of monkeypox in the UK, a patient seemed...

A new approach for extrapolating clinical trial data using adult research aims to speed up and lower the cost of testing and approval of medicines for children. The methodology for attaining such advantages is outlined in a proposed guideline...